VIMTA LABS
Back to Balance Sheet
|
VIMTA LABS Last 5 Year Total Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|
Total Liabilities | ₹358 Cr | ₹305 Cr | ₹273 Cr | ₹245 Cr |
What is the latest Total Liabilities ratio of VIMTA LABS ?
Year | Total Liabilities |
---|---|
Mar2023 | ₹358 Cr |
Mar2022 | ₹305 Cr |
Mar2021 | ₹273 Cr |
Mar2020 | ₹245 Cr |
How is Total Liabilities of VIMTA LABS Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹358 Cr | 17.33 | |
Mar2022 | ₹305 Cr | 11.61 | |
Mar2021 | ₹273 Cr | 11.47 | |
Mar2020 | ₹245 Cr | - |
Compare Total Liabilities of peers of VIMTA LABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VIMTA LABS | ₹1,191.1 Cr | 5.3% | 17.6% | 41.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹360,452.0 Cr | 1.1% | -6.6% | 56.7% | Stock Analytics | |
CIPLA | ₹113,132.0 Cr | 0.2% | -4.4% | 54.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹106,191.0 Cr | 4.8% | 18.9% | 23.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,512.0 Cr | 4.3% | 2.6% | 29.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,954.5 Cr | 2.2% | -4.6% | 86.6% | Stock Analytics |
VIMTA LABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VIMTA LABS | 5.3% |
17.6% |
41.4% |
SENSEX | 1% |
2.8% |
23.9% |
You may also like the below Video Courses